Research Triangle Park, N.C. (November 20, 2003) Five researchers have been awarded 2003 GlaxoSmithKline (GSK) Drug Discovery and Development Research Grants for their efforts to develop new pharmaceutical strategies to combat HIV, the virus that causes AIDS. The recipients, who will share $500,000 in grant money, are: Paul Bieniasz, Ph.D., Associate Professor, Aaron Diamond AIDS Research Center, New York City; Michael Farzan, Ph.D., Assistant Professor, Brigham and Women's Hospital, Boston; Michael Malim, Ph.D., Professor, King's College London, U.K.; Wei Zhang, Ph.D., Senior Scientist, Fluorous Technologies Inc., Pittsburgh; and Ming-Ming Zhou, Ph.D., Associate Professor, Mount Sinai School of Medicine, New York City.
"We are honored to recognize and support the creativity and scientific excellence of these outstanding researchers, whose novel strategies for defeating HIV renew the hope of one day bringing the HIV pandemic to an end, and strengthen our ongoing commitment to the research and development of pharmaceutical therapies against HIV," said Doug Manion, M.D., vice president of clinical development and medical affairs for GSK.
The recipients were announced during the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Chicago in September.
An Expert Review Board, composed of researchers who are leaders in the field of HIV/AIDS, independently judged and selected the award recipients. John A. Bartlett, M.D., professor of medicine at Duke University Medical Center; David D. Ho, M.D., professor at Rockefeller University and scientific director at Aaron Diamond AIDS Research Center; and Michael Saag, M.D., associate professor of medicine and director of the AIDS Outpatient Clinic at the University of Alabama at Birmingham, served on the board this year.
A New System for Screening Compounds in Pharmaceutical "Libraries"
Paul Bieniasz, Ph.D., was awarded a $125,000 Drug Discovery and Development R
'"/>
Contact: Elaine Salewske
esalewske@pcipr.com
312-558-1770
Public Communications Inc.
20-Nov-2003
Page: 1 2 3 4 5 6 Related medicine news :1.
TB Alliance announces new drug discovery program with GlaxoSmithKline2.
GlaxoSmithKline receives unanimous favorable recommendation by FDA Advisory Committee for Boostrix3.
Emory, GlaxoSmithKline, NIMH enter public-private partnership to develop new drugs for depression4.
GlaxoSmithKline Drug Discovery and Development Research Grant Program 20035.
GlaxoSmithKline Drug Discovery and Development Award 20026.
GlaxoSmithKline Drug Discovery and Development Award 20027.
Discovery of pathway in learning impairment caused by liver disease may lead to drug treatment8.
Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine9.
Discovery of the oldest remains of a woman who died in childbirth10.
Discovery sheds light on how cancer cells grow and divide11.
Discovery changes ideas about damage from strokes